A Revolution in
Auto-Injector Technology

Freedom, Without Fear

Pirouette Medical has developed and is bringing to market a revolutionary auto-injector. Auto-injectors are automated injection systems designed to allow self- or caregiver- administration; even by untrained individuals. Pirouette is initially developing an epinephrine auto-injector (EAI), which is used for the emergency treatment of severe allergic reactions. Existing EAIs leave patients actively seeking an alternative to address the anxiety they feel, associated with the affordability, portability, and usability of existing devices. Pirouette Medical is answering that call for something better, delivering a new EAI to revolutionize the marketplace and the overall patient experience. The patented device is portable, intuitive, and easy-to-use. Pirouette is poised to deliver a device that addresses all the major pain points through our human-centered design focus. Beyond EAIs, Pirouette’s technology is diversely applicable to many drugs that require fixed dose, single-use intramuscular or subcutaneous injections. Specifically, we are targeting several emergency applications as well as a number of non-emergency or routine at-home injections.


Meet the Founders

CONOR Cullinane, phd
President & CEO
Matthew kane

Pirouette's revolutionary device brings affordability, portability, and usability directly to the patients that need it, making the administration of an injection as easy as pushing a button. The platform technology is applicable to a wide variety of drugs with both emergency and non-emergency applications.

Conor Cullinane
CEO & President

Recent Articles

View All

Stay Up to Date.